ONCC Practice Tests (OCN - Treatment Modalities) Exam | Questions with 100% Correct Answers | Latest Update 2024 | Verified

ONCC Practice Tests (OCN - Treatment Modalities) Exam | Questions with 100% Correct Answers | Latest Update 2024 | Verified A patient demonstrates an adequate understanding of the teaching provided regarding chemotherapy and myelosuppression by stating: "Myelosuppression is: a potential side effect of many cancer treatments." unintentional prior to a bone marrow transplant." when laboratory values show an elevation in the white blood cell count." the overreaction of the body's immune system to a medication." - a potential side effect of many cancer treatments." Answer: Chemotherapy will decrease the response by the immune system by causing neutropenia, anemia, and thrombocytopenia, collectively known as myelosuppression. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 171. Alkylating agents exert their effects by: binding to DNA strands, preventing DNA replication and cell division. causing the release of toxic free radicals inside the cell, triggering cell hing to CD52 on the surface of B and T cells, resulting in antibody-dependent lysis. disrupting folate-dependent metabolic processes essential for cell replication. - binding to DNA strands, preventing DNA replication and cell division. Answer: Alkalyting agents break the DNA helix strand and interfere with DNA replication. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 27(t). The nurse preparing to instill intravesical mitomycin should wear which of the following pieces of personal protective equipment? A plastic face shield A pair of shoe covers A front-closing laboratory gown One pair of powdered nitrile gloves - A plastic face shield Answer: A plastic face shield should be used when splashing of hazardous drugs is possible. Intravesical administration carries a risk of splashing